The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals Part i

Contact Dermatitis

Volumn 66, Issue SUPPL.1, 2012, Pages 11-24

  Thyssen, Jacob P ^a   Giménez Arnau, Elena ^b   Lepoittevin, Jean Pierre ^b   Menné, Torkil ^a   Boman, Anders ^c   Schnuch, Axel ^d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENT; GLUTATHIONE;

BEUHLER TEST; CELL ACTIVATION; COMPUTER MODEL; DIRECT PEPTIDE REACTIVITY ASSAY; GUINEA PIG MAXIMIZATION TEST; HUMAN; HUMAN REPEATED INSULT PATCH TEST; IN VITRO STUDY; IN VIVO STUDY; LOCAL LYMPH NODE ASSAY; METHODOLOGY; MOUSE EAR SWELLING TEST; NONHUMAN; PATCH TEST; QUANTITATIVE ASSAY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SKIN ALLERGY; SKIN SENSITIZATION; SKIN TEST; STRUCTURE ACTIVITY RELATION;

ALLERGENS; ANIMALS; CONSUMER PRODUCT SAFETY; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, OCCUPATIONAL; EUROPE; HUMANS; SKIN TESTS;

EID: 84858139788     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2011.02004_2.x     Document Type: Review

References (89)

1. Draize J H, Woodard G, Calvery H O., Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944: 82: 377-390.
2. Magnusson B, Kligman A., The identification of contact allergens by animal assay, the guinea pig maximization test method. J Invest Dermatol 1969: 52: 268-276.
3. Beuhler E V., Delayed contact hypersensitivity in the guinea pig. Arch Dermatol 1965: 91: 171-177.
4. OECD. Guidelines for testing of chemicals, 1992. Guideline No. 406. Skin sensitization.
5. OECD. Guidelines for testing of chemicals, 2002. Guideline No. 429. Skin sensitization: Local Lymph Node Assay.
6. Andersen K E, Boman A, V̧lund A, Wahlberg J E., Induction of formaldehyde contact sensitivity: dose response relationship in the guinea pig maximization test. Acta Derm Venereol 1985: 65: 472-478. (Pubitemid 16204652)
7. Gad S C, Dunn B J, Dobbs D W, Reilly C, Walsh R D., Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol Appl Pharmacol 1986: 84: 93-114. (Pubitemid 16090788)
8. Gad S C., The mouse ear swelling test (MEST) in the 1990s. Toxicology 1994: 93: 33-46. (Pubitemid 24325714)
9. Kimber I, Hilton J, Weisenberger C., The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis 1989: 21: 215-220. (Pubitemid 19250323)
10. Homey B, von-Schilling C, Blumel J, Schuppe H C, Ruzicka T, Ahr H J, Lehmann P, Vohr H W., An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions. Toxicol Appl Pharmacol 1998: 153: 83-94. (Pubitemid 28563892)
11. Basketter D A, Andersen K E, Lidén C, Van Loveren H, Boman A, Kimber I, Alanko K, Berggren E., Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis 2005: 52: 39-43. (Pubitemid 40293090)
12. Marzulli F N, Maibach H I., Antimicrobials: experimental contact sensitization in man. J Soc Cosmet Chem 1973: 24: 399-421.
13. European Commission, Scientific Committee on Cosmetic Products and Non-Food Products. Opinion concerning the predictive testing of potentially cutaneous sensitizing cosmetic ingredients or mixtures of ingredients adopted by the SCCNFP during the 11th plenary session of 17 February 2000. Available at: http://ec.europa.eu/health/scientific-committees/consumer-safety/opinions/ sccnfp-opinions-97-04/sccp-out102-en.htm (last accessed 20 January 2012).
14. Api A M, Basketter D A, Cadby P A et al., Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol 2008: 52: 3-23.
15. Merk H F, Baron J, Hertl M, Niederau D, Rübben A., Lymphocyte activation in allergic reactions elicited by small-molecular-weight compounds. Int Arch Allergy Immunol 1997: 113: 173-176. (Pubitemid 27160750)
16. Lisby S, Hansen L H, Skov L, Menné T, Baadsgaard O., Nickel-induced activation of T cells in individuals with negative patch test to nickel sulphate. Arch Dermatol Res 1999: 291: 247-252. (Pubitemid 29225049)
17. Lessmann H, Uter W, Geier J, Schnuch A., Die Informations- und dokumentationsstelle für Kontaktallergien (IDOK) des Informationsverbundes dermatologischer Kliniken (IVDK). Dermatol Beruf Umwelt 2006: 54: 160-166. (Pubitemid 46087068)
18. Geier J, Lessmann H, Frosch P J et al., Patch testing with components of water-based metalworking fluids. Contact Dermatitis 2003: 49: 85-90. (Pubitemid 37523851)
19. Uter W, Geier J, Lessmann H, Schnuch A., Is contact allergy to glyceryl monothioglycolate still a problem in Germany? Contact Dermatitis 2006: 55: 54-56. (Pubitemid 43989903)
20. Schnuch A, Uter W, Geier J, Lessmann H, Hillen U., Contact allergies to water-based paints. Surveillance through the IVDK, intervention of the Federal Environmental Agency and successful primary prevention. (Kontaktallergien gegen Dispersionsfarben. Epidemiologische œberwachung durch den IVDK, Intervention des Umweltbundesamtes und erfolgreiche Primärprävention). Allergo J 2002: 11: 39-47.
21. White J M, Gilmour N J, Jeffries D, Duangdeeden I, Kullavanijaya P, Basketter D A, McFadden J P., A general population from Thailand: incidence of common allergens with emphasis on para-phenylenediamine. Clin Exp Allergy 2007: 37: 1848-1853. (Pubitemid 350145342)
22. Kimber I, Dearman R J, Betts C J, Gerberick G F, Ryan C A, Kern P S, Patlewicz G Y, Basketter D A., The local lymph node assay and skin sensitization: a cut-down screen to reduce animal requirements? Contact Dermatitis 2006: 54: 181-185.
23. Ryan C A, Chaney J G, Kern P S et al., The reduced local lymph node assay: the impact of group size. J Appl Toxicol 2008: 28: 518-523. (Pubitemid 351716536)
24. Vandenberg J J, Epstein W L., Experimental nickel contact sensitization in man. J Invest Dermatol 1963: 41: 413-418.
25. Kligman A M., The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol 1966: 47: 393-409.
26. Suskind R R., The hydroxycitronellal story: what can we learn from it? In: Fragrances -Beneficial and Adverse Effects, Frosch P J, Johansen J D, White I R, (eds): Heidelberg, Springer, 1998: pp. 159-165.
27. Johansen J D, Frosch P J, Menné T., Allergic contact dermatitis in humans -experimental and quantitative aspects. In: Contact Dermatitis, Frosch P J, Menné T, Lepoittevin J-P, (eds): Heidelberg, Springer, 2005: pp. 189-198.
28. Emmett E A, Risby T H, Jiang L, Ng S K, Feinman S., Allergic contact dermatitis to nickel: bioavailability from consumer products and provocation threshold. J Am Acad Dermatol 1988: 19: 314-322.
29. Hansen M B, Rydin S, Menné T, Duus J J., Quantitative aspects of contact allergy to chromium and exposure to chrome-tanned leather. Contact Dermatitis 2002: 47: 127-134. (Pubitemid 36051378)
30. Fischer L A, Menné T, Johansen J D., Experimental nickel elicitation thresholds -a review focusing on occluded nickel exposure. Contact Dermatitis 2005: 52: 57-64. (Pubitemid 40343852)
31. Fischer L A, Menné T, Völund A, Johansen J D., Can exposure limitations for well-known contact allergens be simplified?-an analysis of dose-response patch test data. Contact Dermatitis 2011: 64: 337-342.
32. Hannuksela M, Salo H., The repeated open application test (ROAT). Contact Dermatitis 1986: 14: 221-227. (Pubitemid 16114439)
33. Fischer L A, Menné T, Johansen J D., Dose per unit area -a study of elicitation of nickel allergy. Contact Dermatitis 2007: 56: 255-261. (Pubitemid 46624101)
34. Hannuksela M., Sensitivity of various skin sites in the repeated open application test. Am J Contact Dermat 1991: 2: 102-104.
35. Johansen J D, Bruze M, Andersen K E et al., The repeated open application test: suggestions for a scale of evaluation. Contact Dermatitis 1998: 39: 95-96. (Pubitemid 28410026)
36. Fischer L A, Völund A, Andersen K E, Menné T, Johansen J D., The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes. Contact Dermatitis 2009: 61: 201-208.
37. Fischer L A, Johansen J D, Menné T., Nickel allergy: relationship between patch test and repeated open application test thresholds. Br J Dermatol 2007: 157: 723-729. (Pubitemid 47389885)
38. Schnuch A, Uter W, Dickel H et al., Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde sensitive-patients. Contact Dermatitis 2009: 61: 152-162.
39. Schnuch A, Uter W, Lessmann H, Arnold R, Geier J., Klinische epidemiologie der kontaktallergien: das register und das überwachungssystem des IVDK. Eine œbersicht. Allergo J 2008: 17: 611-624.
40. Uter W, Rämsch C, Aberer W, et al., The European baseline series in 10 European countries, 2005/2006-results of the European Surveillance system on contact allergies (ESSCA). Contact Dermatitis 2009: 61: 31-38.
41. Uter W, Gefeller O, Geier J, Lessmann H, Pfahlberg A, Schnuch A., Untersuchungen zur Abhängigkeit der Sensibilisierung Gegen Wichtige Allergene von Arbeitsbedingten Sowie Individuellen Faktoren, Schriftenreihe der Bundesanstalt für Arbeitsschutz und Arbeitsmedizin Fb 949, Bremerhaven, Wirtschaftsverlag NW, 2002.
42. Uter W, Schnuch A, Geier J, Pfahlberg A, Gefeller O., Association between occupation and contact allergy to the fragrance mix: a multifactorial analysis of national surveillance data. Occup Environ Med 2001: 58: 392-398. (Pubitemid 32488094)
43. Uter W, Pfahlberg A, Gefeller O, Geier J, Schnuch A., Risk factors for contact allergy to nickel -results of a multifactorial analysis. Contact Dermatitis 2003: 48: 33-38. (Pubitemid 36428413)
44. Menezes-de-Padua C A, Schnuch A, Lessmann H, Geier J, Pfahlberg A, Uter W., Contact allergy to neomycin sulfate -results of a multifactorial analysis. Pharmacoepidemiol Drug Saf 2005: 14: 725-733. (Pubitemid 41489453)
45. Schnuch A, Lessmann H, Frosch P J, Uter W., para-Phenylenediamine: the profile of an important allergen. Results of the IVDK. Br J Dermatol 2008: 159: 379-386. (erratum: 772). (Pubitemid 352009841)
46. Uter W, Rühl R, Pfahlberg A, Geier J, Schnuch A, Gefeller O., Contact allergy in construction workers: results of a multifactorial analysis. Ann Occup Hyg 2004: 48: 21-27. (Pubitemid 38112049)
47. Menezes-de-P dua C A, Schnuch A, Nink K, Pfahlberg A, Uter W., Allergic contact dermatitis to topical drugs-epidemiological risk assessment. Pharmacoepidemiol Drug Saf 2008: 17: 813-821.
48. Schnuch A, Uter W, Geier J, Gefeller O., Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug utilisation research (CE-DUR) approach. Contact Dermatitis 2002: 47: 32-39.
49. Schnuch A, Lessmann H, Schulz K H et al., When should a substance be designated as sensitizing for the skin ('Sh') or for the airways ('Sa'). Hum Exp Toxicol 2002: 21: 439-444. (Pubitemid 35256453)
50. Schnuch A, Lessmann H, Becker D et al., Designation of substances as skin sensitizing chemicals: a reply. Hum Exp Toxicol 2005: 24: 157-159. (Pubitemid 40605156)
51. Kimber I, Dearman R J, Gerberick G F, Roggeband R, Basketter D A., Designation of substances as skin sensitizing chemicals: a commentary. Hum Exp Toxicol 2003: 22: 439-443. (Pubitemid 37038838)
52. Nagao S, Tanaka A., Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli. J Exp Med 1985: 162: 401-412. (Pubitemid 15249948)
53. Leenaars P P, Hendriksen C F, Koedam M A, Claassen I, Claassen E., Comparison of adjuvants for immune potentiating properties and side effects in mice. Vet Immunol Immunopathol 1995: 48: 123-138.
54. Council Directive of 27 July 1976: on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC). Off J Eur Union 1976: L 262: 169.
55. Scientific Committee on Consumer Products, SCCP. Memorandum on actual status of alternative methods on the use of experimental animals in the safety assessment of cosmetic ingredients in the European Union. adopted 12th plenary, 19 June 2007: 1-163.
56. World Medical Association Declaration of Helsinki. 2007 Ethical principles for medical research involving human subjects. In: Adopted by the 18th WMA General Assembly, Helsinki, June 1964: with amendments 2008.
57. ECHA. Guidance on information requirements and chemical safety assessment Chapter R.7a: endpoint specific guidance, 2008. Available at: http://guidance.echa.europa.eu/docs/guidance-document/information-requirements- r7a-en.pdf?vers=20-08-08 (last accessed 25 May 2010).
58. ECHA. Guidance on information requirements and chemical safety assessment Chapter R.8: characterisation of dose [concentration]-response for human health, 2008. Available at: http://guidance.echa.europa.eu/docs/guidance- document/information-requirements-r8-en.pdf?vers=20-08-08 (last accessed 25 May 2010).
59. th Amendment to the European Cosmetics Directive'). Off J Eur Union 2003: L66: 26-35.
60. European Union. Regulation 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) 793/93 and Commission Regulation (EC) 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off J Eur Union 2006: L396/1: 1-849.
61. OECD. The Report from the Expert Group on (Quantitative) Structure-Activity Relationships [(Q)SARs] on the Principles for the Validation of (Q)SARs, ENV/JM/TG(2004)27/ REV. Paris, Organisation for Economic Cooperation and Development. Available at: (last accessed 20 January 2012).
62. OECD. Guidance Document on the Validation of (Quantitative) Structure-Activity Relationships [(Q)SAR] Models, ENV/JM/MONO(2007)2. Paris, Organisation for Economic Cooperation and Development. Available at: (last accessed 20 January 2012).
63. Landsteiner K, Jacobs J., Studies on the sensitization of animals with simple chemical compounds. From the Laboratories of The Rockefeller Institute for Medical Research. J Exp Med 1936: 625-639.
64. Dupuis G, Benezra C., Allergic Contact Dermatitis to Simple Chemicals. A Molecular Approach, New York, Marcel Dekker, 1982.
65. Ashby J, Basketter D A, Paton D, Kimber I., Structure activity relationships in skin sensitization using the murine local lymph node assay. Toxicology 1995: 103: 177-194. (Pubitemid 26008365)
66. Barratt M D, Basketter D A, Chamberlain M, Admans G D, Langowski J J., An expert system rulebase for identifying contact allergens. Toxicol In Vitro 1994: 8: 1053-1060. (Pubitemid 24325769)
67. Payne M P, Walsh P T., Structure-activity relationships for skin sensitization potential: development of structural alerts for use in knowledge-based toxicity prediction systems. J Chem Inf Comput Sci 1994: 34: 154-161.
68. Patlewicz G, Aptula A O, Roberts D W, Uriarte E., A mini-review of available skin sensitization (Q)SARs/expert systems. QSAR Comb Sci 2008: 27: 60-76. (Pubitemid 351204935)
69. Roberts D W, Williams D L., The derivation of quantitative correlations between skin sensitisation and physiochemical parameters for alkylating agents, and their application to experimental data for sultones. J Theor Biol 1982: 99: 807-825. (Pubitemid 13192311)
70. Aptula A O, Patlewicz G, Roberts D W., Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships. Chem Res Toxicol 2005: 18: 1420-1426. (Pubitemid 41361715)
71. Roberts D W, Patlewicz G, Kern P S et al., Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem Res Toxicol 2007: 20: 1019-1030. (Pubitemid 47204815)
72. Roberts D W, Aptula A O, Patlewicz G., Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chem Res Toxicol 2006: 19: 1228-1233. (Pubitemid 44454040)
73. Langton K, Patlewicz G, Long A, Marchant C A, Basketter D A., Structure-activity relationships for skin sensitization: recent improvements to Derek for Windows. Contact Dermatitis 2006: 55: 342-347. (Pubitemid 44730152)
74. OECD. OECD quantitative structure-activity relationships [(Q)SARs] project, 2010. Available at: http://www.oecd.org/document/23/0,3343,en-2649- 34379-33957015-1-1-1-1,00.html (last accessed January 2012).
75. Gerberick G F, Aleksic M, Basketter D A et al., Chemical reactivity measurement and the predictive identification of skin sensitisers. ATLA 2008: 36: 215-242. (Pubitemid 351861004)
76. Aptula A O, Patlewicz G, Roberts D W, Schultz T W., Non-enzymatic glutathione reactivity and in vitro toxicity: a non animal approach to skin sensitisation. Toxicol in Vitro 2006: 20: 239-247. (Pubitemid 43087707)
77. Gerberick G F, Vassallo J, Bailey R, Morrall S, Lepoittevin J-P., Development of peptide reactivity assay for screening contact allergens. Toxicol Sci 2004: 81: 332-343. (Pubitemid 39377963)
78. Gerberick F, Vassallo J, Foertsch L, Price B, Chaney J, Lepoittevin J-P., Quantification of chemical peptide reactivity for screening contact allergens. Toxicol Sci 2007: 97: 417-427. (Pubitemid 47073857)
79. Natsch A, Gfeller H, Rothaupt M, Ellis G., Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. Toxicol in Vitro 2007: 21: 1220-1226. (Pubitemid 350030873)
80. Gerberick G F, Troutman J A, Foertsch L M, Quijano M, Dobson R L, Goebel C, Lepoittevin J-P., Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol Sci 2009: 112: 164-174.
81. Casati S, Aeby P, Basketter D A et al., Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. ATLA 2005: 33: 47-62. (Pubitemid 40476882)
82. Aiba S, Terunuma A, Manome H, Tagami H., Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997: 27: 3031-3038. (Pubitemid 27478378)
83. Hopper U, Degwerat J, Steckel F., Use of CD1a dendritic cells and keratinocytes to characterize cellular reaction involved in allergic contact dermatitis. J Cell Biochem 1995: 21 (SUPPL. A): 11-18.
84. Becker D, Kuhn U, Lempertz U, Enk A, Saloga J, Knop J., Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: implications for the development of an in vitro technique for predictive testing of contact sensitizers. J Immunol Methods 1997: 203: 171-180. (Pubitemid 27179616)
85. Ashikaga T, Yoshida Y, Hirota M et al., Development of an in vitro skin sensitization test using human cell lines: the human cell line activation test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicol in Vitro 2006: 20: 767-773. (Pubitemid 43948877)
86. Sakaguchi H, Ashikaga T, Miyazawa M et al., Development of an in vitro skin sensitization test using human cell lines; human cell line activation test (h-CLAT) II. An inter-laboratory study of the h-CLAT. Toxicol in Vitro 2006: 20: 774-784. (Pubitemid 43948878)
87. Sakaguchi H, Ashikaga T, Miyazawa M et al., The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test -human cell line activation test (h-CLAT). Cell Biol Toxicol 2009: 25: 109-126.
88. Rousset F, Verda D, Garrigue J L, Mariani M, Leclaire J., In vitro prediction of contact sensitivity with human cell lines. Contact Dermatitis 2002: 46 (SUPPL. 4): 6.
89. Python F, Goebel C, Aeby P., Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol 2007: 220: 113-124. (Pubitemid 46507571)